BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18199244)

  • 1. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Licht RW; Vestergaard P; Brodersen A
    Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mortality in patients with affective disorder who commenced treatment with lithium. A 16-year follow-up].
    Brodersen A; Licht RW; Vestergaard P; Olesen AV; Mortensen PB
    Ugeskr Laeger; 2001 Nov; 163(46):6428-32. PubMed ID: 11816921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features.
    Craig TJ; Grossman S; Mojtabai R; Gibson PJ; Lavelle J; Carlson GA; Bromet EJ
    Bipolar Disord; 2004 Oct; 6(5):406-15. PubMed ID: 15383133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.
    Mauri MC; Laini V; Scalvini ME; Volonteri LS; Ferrari MS; Panza G
    Eur Rev Med Pharmacol Sci; 1999; 3(2):63-9. PubMed ID: 10827806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder.
    Jaeger J; Berns S; Loftus S; Gonzalez C; Czobor P
    Bipolar Disord; 2007; 9(1-2):93-102. PubMed ID: 17391353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.
    Gonzalez-Pinto A; Mosquera F; Alonso M; López P; Ramírez F; Vieta E; Baldessarini RJ
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):618-24. PubMed ID: 17042834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical predictors of long-term outcome of lithium prophylaxis in bipolar disorder].
    Garcia-López A; Ezquiaga E; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2001; 29(5):327-32. PubMed ID: 11602090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.
    Pfennig A; Schlattmann P; Alda M; Grof P; Glenn T; Müller-Oerlinghausen B; Suwalska A; Rybakowski J; Willich SN; Bauer M; Berghöfer A
    Bipolar Disord; 2010 Jun; 12(4):390-6. PubMed ID: 20636636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
    Tondo L; Baldessarini RJ; Floris G
    Br J Psychiatry Suppl; 2001 Jun; 41():s184-90. PubMed ID: 11450181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of excellent response to lithium: results from a nationwide register-based study.
    Kessing LV; Hellmund G; Andersen PK
    Int Clin Psychopharmacol; 2011 Nov; 26(6):323-8. PubMed ID: 21876441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode.
    Storosum JG; Wohlfarth T; Schene A; Elferink A; van Zwieten BJ; van den Brink W
    Bipolar Disord; 2007 Dec; 9(8):793-8. PubMed ID: 18076528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive effect of insight on adverse clinical outcomes in bipolar I disorder: a two-year prospective study.
    Yen CF; Chen CS; Yen JY; Ko CH
    J Affect Disord; 2008 May; 108(1-2):121-7. PubMed ID: 17997489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.